Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.2%

18 terminated/withdrawn out of 558 trials

Success Rate

88.5%

+2.0% vs industry average

Late-Stage Pipeline

10%

58 trials in Phase 3/4

Results Transparency

4%

5 of 139 completed trials have results

Key Signals

139 recruiting5 with results7 terminated11 withdrawn

Enrollment Performance

Analytics

N/A
130(32.3%)
Phase 2
81(20.1%)
Phase 1
78(19.4%)
Early Phase 1
55(13.7%)
Phase 3
36(9.0%)
Phase 4
22(5.5%)
402Total
N/A(130)
Phase 2(81)
Phase 1(78)
Early Phase 1(55)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (558)

Showing 20 of 558 trials
NCT07736612Phase 1Not Yet Recruiting

A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer

Role: lead

NCT07729917Phase 2Not Yet Recruiting

Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An Umbrella Platform Study

Role: lead

NCT06822192Not ApplicableCompleted

The Temporally Interfering in Patients With Disorders of Consciousness

Role: collaborator

NCT05824923Phase 3Active Not Recruiting

A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure

Role: collaborator

NCT04930315Phase 2Completed

SHR-1210 Combined With Apatinib Mesylate in the Perioperative Therapy for Hepatocellular Carcinoma

Role: lead

NCT07246707Phase 1Recruiting

KSV01 Injection as the Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Role: lead

NCT06859840Not ApplicableRecruiting

LEAF (Liver Tumor dEtection And classiFication AI)

Role: lead

NCT06464965Phase 1Completed

Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer

Role: collaborator

NCT07102953Not ApplicableCompleted

Mindfulness on Creativity

Role: lead

NCT07662382Not Yet Recruiting

Cousin vs. Sibling Donors in Haplo-HSCT

Role: collaborator

NCT06740149Phase 1Completed

Efficacy and Safety of BMSCs (CG-BM1) for ACLF Patients

Role: collaborator

NCT05818644Completed

Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children

Role: collaborator

NCT05089500Not ApplicableCompleted

Endoscopic Injection Sclerotherapy Versus Endoscopic Band Ligation for Grade I-III Internal Hemorrhoids

Role: collaborator

NCT07644247Phase 4Not Yet Recruiting

STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump

Role: collaborator

NCT07644104Not ApplicableNot Yet Recruiting

Efficacy and Safety of the Visual Bronchial Blocker for Lung Isolation Surgery

Role: lead

NCT07644026Not Yet Recruiting

HBV Reactivation Prediction Model in Allo-HSCT

Role: collaborator

NCT05593458Phase 3Recruiting

Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1

Role: lead

NCT07550881Phase 2Recruiting

Intranasal Dexmedetomidine for Acute Anxiety State in Adults

Role: collaborator

NCT07637721Not ApplicableNot Yet Recruiting

Supraglottic Oxygenation Via Oral Transtracheal Catheter for Reducing the Incidence of Hypoxemia During ERCP Under Sedation

Role: lead

NCT07302009Not ApplicableRecruiting

Targeted Temperature Management Via Bladder Monitoring in ICH

Role: collaborator